Rival drugmakers want to upend Pfizer’s dominance of the $7 billion worldwide market for pneumonia vaccines
Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles.
Merck & Co. has already introduced a new competitor to Pfizer’s Prevnar vaccine franchise, while GSK PLC and Vaxcyte Inc. are among companies developing shots that aim to win sales by protecting against even more strains of the pneumonia virus.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
George Lopez squares off with daughter Mayan in 'Lopez vs. Lopez'Mayan Lopez remembers being 7 or 8 on the set of her father’s sitcom, “The George Lopez Show.” To earn extra money, she did odd jobs as an assistant director,
Read more »
Jake Paul vs. Anderson Silva: YouTube superstar squares off against MMA legend in boxing matchJake Paul and Anderson Silva will be the main event in a catchweight boxing match Saturday night at the Gila River Arena in Glendale, Arizona.
Read more »
Rising RSV respiratory virus hits kids hard, fills pediatric wards in Greater ClevelandUH Rainbow and Children’s Hospital is seeing double the number of children with RSV in their emergency department, compared with a month ago. And MetroHealth has seen a 500% increase in the past month.
Read more »
Fully kicks off its November site-wide sale with 20 percent off everythingSome of our favorite standing desks are on sale.
Read more »